Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm & Corp Aff Officer
Feb 17, 2026
Sale
Shares
200
Price
$155.62
Total Value
$31.12K
Shares Held After
120,288
% of Holdings
0.2%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm & Corp Aff Officer
Feb 17, 2026
Sale
Shares
9,395
Price
$154.91
Total Value
$1.46M
Shares Held After
120,488
% of Holdings
7.2%

GILEAD SCIENCES, INC. (GILD)

Mercier Johanna — Chief Comm & Corp Aff Officer
Feb 17, 2026
Sale
Shares
18,405
Price
$154.18
Total Value
$2.84M
Shares Held After
129,883
% of Holdings
12.4%
Feb 17, 2026
Purchase
Shares
76,857
Price
$1.31
Total Value
$100.54K
Shares Held After
1,520,498
% of Holdings
5.1%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 17, 2026
Sale
Shares
7,875
Price
$480.75
Total Value
$3.79M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 17, 2026
Sale
Shares
14,625
Price
$480.75
Total Value
$7.03M
Shares Held After
0
% of Holdings
100.0%

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Hodgson Ian — Chief Operating Officer
Feb 17, 2026
Sale
Shares
847
Price
$7.38
Total Value
$6.25K
Shares Held After
51,080
% of Holdings
1.6%

OMNICELL, INC. (OMCL)

Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Feb 17, 2026
Sale
Shares
4,243
Price
$36.59
Total Value
$155.25K
Shares Held After
85,496
% of Holdings
4.7%

EyePoint, Inc. (EYPT)

Ribeiro Ramiro — Chief Medical Officer
Feb 17, 2026
Sale
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
Feb 17, 2026
Sale
Shares
6,000
Price
$16.08
Total Value
$96.48K
Shares Held After
2,284,379
% of Holdings
0.3%
Feb 17, 2026
Sale
Shares
15,000
Price
$16.08
Total Value
$241.20K
Shares Held After
2,290,379
% of Holdings
0.7%

Gemini Therapeutics, Inc. (GMTX)

Yu Jonathan Yen-Wen — Chief Operating Officer
Feb 17, 2026
Sale
Shares
3,231
Price
$62.86
Total Value
$203.10K
Shares Held After
54,324
% of Holdings
5.6%
Feb 17, 2026
Sale
Shares
13,264
Price
$62.86
Total Value
$833.78K
Shares Held After
226,064
% of Holdings
5.5%

Gemini Therapeutics, Inc. (GMTX)

Savage William Jacob — Chief Medical Officer
Feb 17, 2026
Sale
Shares
3,256
Price
$62.86
Total Value
$204.67K
Shares Held After
92,589
% of Holdings
3.4%

Gemini Therapeutics, Inc. (GMTX)

Khara Rahul — Chief Legal Officer
Feb 17, 2026
Sale
Shares
2,853
Price
$62.86
Total Value
$179.34K
Shares Held After
52,173
% of Holdings
5.2%

Gemini Therapeutics, Inc. (GMTX)

Stephenson Pamela — Chief Commercial Officer
Feb 17, 2026
Sale
Shares
5,531
Price
$62.86
Total Value
$347.68K
Shares Held After
80,998
% of Holdings
6.4%

PULSE BIOSCIENCES, INC. (PLSE)

Danahy Kevin Patrick — Chief Commercial Officer
Feb 17, 2026
Sale
Shares
20,000
Price
$23.63
Total Value
$472.60K
Shares Held After
43,298
% of Holdings
31.6%
Feb 17, 2026
Sale
Shares
47,648
Price
$5.06
Total Value
$241.10K
Shares Held After
409,815
% of Holdings
10.4%

Aura Biosciences, Inc. (AURA)

Hopkins Janet Jill — Chief Medical Officer
Feb 17, 2026
Sale
Shares
20,401
Price
$5.06
Total Value
$103.23K
Shares Held After
232,284
% of Holdings
8.1%

Aura Biosciences, Inc. (AURA)

Elazzouzi Amy — Senior Vice President, Finance
Feb 17, 2026
Sale
Shares
8,549
Price
$5.06
Total Value
$43.26K
Shares Held After
75,532
% of Holdings
10.2%

Aura Biosciences, Inc. (AURA)

Plavsic Mark — Chief Technology Officer
Feb 17, 2026
Sale
Shares
15,890
Price
$5.05
Total Value
$80.24K
Shares Held After
181,397
% of Holdings
8.1%

Aura Biosciences, Inc. (AURA)

Kilroy Conor — Chief Legal Officer and Secretary.
Feb 17, 2026
Sale
Shares
12,079
Price
$5.05
Total Value
$61.00K
Shares Held After
167,234
% of Holdings
6.7%
Feb 17, 2026
Sale
Shares
30,000
Price
$20.63
Total Value
$618.99K
Shares Held After
997,015
% of Holdings
2.9%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore — Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,876
Price
$0.64
Total Value
$1.21K
Shares Held After
218,618
% of Holdings
0.9%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore — Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
220,494
% of Holdings
0.7%

Tenaya Therapeutics, Inc. (TNYA)

Tingley Whittemore — Chief Medical Officer
Feb 17, 2026
Sale
Shares
1,642
Price
$0.64
Total Value
$1.06K
Shares Held After
222,136
% of Holdings
0.7%
Feb 17, 2026
Sale
Shares
5,032
Price
$0.64
Total Value
$3.24K
Shares Held After
443,404
% of Holdings
1.1%
Feb 17, 2026
Sale
Shares
3,979
Price
$0.64
Total Value
$2.56K
Shares Held After
448,436
% of Holdings
0.9%
Feb 17, 2026
Sale
Shares
5,851
Price
$0.64
Total Value
$3.76K
Shares Held After
452,415
% of Holdings
1.3%
Feb 17, 2026
Sale
Shares
2,022
Price
$0.64
Total Value
$1.30K
Shares Held After
119,752
% of Holdings
1.7%
Feb 17, 2026
Sale
Shares
836
Price
$0.64
Total Value
$537.88
Shares Held After
121,774
% of Holdings
0.7%
Feb 17, 2026
Sale
Shares
611
Price
$0.64
Total Value
$393.12
Shares Held After
122,610
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Feb 17, 2026
Sale
Shares
2,041
Price
$331.96
Total Value
$677.53K
Shares Held After
21,264
% of Holdings
8.8%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Feb 17, 2026
Sale
Shares
417
Price
$27.59
Total Value
$11.51K
Shares Held After
44,089
% of Holdings
0.9%
Feb 17, 2026
Sale
Shares
6,990
Price
$1.70
Total Value
$11.88K
Shares Held After
383,623
% of Holdings
1.8%

Avista Public Acquisition Corp. II (AHPA)

GUSTAFSON KURT A — Executive VP, Finance and CFO
Feb 17, 2026
Sale
Shares
6,828
Price
$1.70
Total Value
$11.61K
Shares Held After
259,402
% of Holdings
2.6%
Feb 17, 2026
Sale
Shares
20,754
Price
$1.70
Total Value
$35.28K
Shares Held After
4,375,787
% of Holdings
0.5%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Feb 17, 2026
Sale
Shares
936
Price
$32.78
Total Value
$30.69K
Shares Held After
34,018
% of Holdings
2.7%

Oruka Therapeutics, Inc. (ORKA)

Goncalves Joana — Chief Medical Officer
Feb 17, 2026
Sale
Shares
6,064
Price
$32.30
Total Value
$195.87K
Shares Held After
34,954
% of Holdings
14.8%
Feb 17, 2026
Sale
Shares
50
Price
$474.68
Total Value
$23.73K
Shares Held After
220
% of Holdings
18.5%

Zoetis Inc. (ZTS)

PECK KRISTIN C — Director
Feb 17, 2026
Sale
Shares
10,800
Price
$127.55
Total Value
$1.38M
Shares Held After
101,337
% of Holdings
9.6%

Zoetis Inc. (ZTS)

PECK KRISTIN C — Director
Feb 17, 2026
Sale
Shares
9,200
Price
$126.46
Total Value
$1.16M
Shares Held After
112,137
% of Holdings
7.6%
Feb 17, 2026
Purchase
Shares
23
Price
$10.94
Total Value
$251.62
Shares Held After
704
% of Holdings
3.3%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Feb 17, 2026
Purchase
Shares
1,200
Price
$1.31
Total Value
$1.57K
Shares Held After
119,890
% of Holdings
1.0%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Feb 17, 2026
Purchase
Shares
1,000
Price
$1.37
Total Value
$1.37K
Shares Held After
118,690
% of Holdings
0.8%

Seres Therapeutics, Inc. (MCRB)

Henn Matthew R — Chief Scientific Officer and EVP
Feb 15, 2026
Sale
Shares
89
Price
$8.47
Total Value
$753.83
Shares Held After
7,677
% of Holdings
1.1%

Seres Therapeutics, Inc. (MCRB)

DesRosier Thomas — Chief Legal Officer, EVP, Co-Chief Executive Officer, and Co-President
Feb 15, 2026
Sale
Shares
78
Price
$8.47
Total Value
$660.66
Shares Held After
7,789
% of Holdings
1.0%

Seres Therapeutics, Inc. (MCRB)

Young Teresa L. — EVP, Chief Commercial & Strategy Officer
Feb 15, 2026
Sale
Shares
75
Price
$8.47
Total Value
$635.25
Shares Held After
8,557
% of Holdings
0.9%
Feb 15, 2026
Sale
Shares
259
Price
$8.47
Total Value
$2.19K
Shares Held After
11,577
% of Holdings
2.2%
Feb 15, 2026
Sale
Shares
286,122
Price
$34.22
Total Value
$9.79M
Shares Held After
605,771
% of Holdings
32.1%
Version: v26.3.33